Pneumabort-K+1b (Canada)This page contains information on Pneumabort-K+1b for veterinary use.
The information provided typically includes the following:
- Pneumabort-K+1b Indications
- Warnings and cautions for Pneumabort-K+1b
- Direction and dosage information for Pneumabort-K+1b
Pneumabort-K+1bThis treatment applies to the following species:
Equine Rhinopneumonitis Vaccine
For the vaccination of healthy horses as an aid in the prevention of respiratory diseases caused by the EHV 1p and EHV 1b viruses as well as for use in pregnant mares as an aid in the prevention of abortion due to EHV 1 infections.
ADMINISTRATION AND DOSAGE: For pregnant mares, aseptically administer one 2 mL dose intramuscularly during the 5th, 7th and 9th months of pregnancy. Revaccinate annually at the 5th, 7th and 9th months of pregnancy.
For young horses, administer one 2 mL dose intramuscularly followed by a second 2 mL dose 3 to 4 weeks later. Revaccinate with a single 2 mL dose 6 months after the second primary dose and annually thereafter. To insure proper placement and retention of the vaccine, inject deep into the heavy muscles of the hindquarter. Mild exercise to promote absorption is recommended for one week after injection. Maiden and barren mares kept in barn- or pasture-contact with vaccinated pregnant mares should be vaccinated on the same schedule as the pregnant mares with which they are in contact. Mares more than five months pregnant at the time of arrival on a farm should be vaccinated upon arrival and at two-month intervals until foaling.
Pregnant mares that are in contact with mares that have aborted equine herpesvirus 1 infected fetuses should be vaccinated. Such vaccination may provide immunity for those mares in the group which are not incubating an abortigenic infection at the time of vaccination.
Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE VIGOROUSLY to assure uniform suspension of the vaccine. Do not vaccinate within 60 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.
Thimerosal, neomycin, polymyxin B and amphotericin B added as preservatives.
For Veterinary Use Only
For Use in Horses Only
Remove serial number and expiration date label and place on the animal’s medical chart.
U.S. Patent No. 5,084,271
© 2004 Fort Dodge Animal Health. All Rights Reserved.
Manufactured by Fort Dodge Animal Health, Fort Dodge, Iowa 50501 U.S.A.
U.S. Vet. License No. 112
Trademarks used under license
Distributed in Canada by Wyeth Animal Health, Division of Wyeth Canada, Guelph, Ontario, Canada
NAC No.: 11983971
17,300 TRANS-CANADA HIGHWAY, KIRKLAND, QC, H9J 2M5
|Technical Services Canada:||800-461-0917|
|Technical Services USA:||800-366-5288|
|Every effort has been made to ensure the accuracy of the Pneumabort-K+1b information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2014 North American Compendiums. Updated: 2013-12-23